substance p has been researched along with Apnea, Obstructive Sleep in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharjee, R; Goldman, JL; Gozal, D; Kheirandish-Gozal, L; Kim, J | 1 |
| Chen, WW; Guo, WF; Huang, H; Huang, HB; Zhuang, XB | 1 |
| Li, H; Meng, X; Yang, H | 1 |
| Groswasser, J; Kadhim, H; Kahn, A; Nishida, H; Ozawa, Y; Patricia, F; Sawaguchi, T; Sottiaux, M; Takashima, S | 1 |
| Burgazlioglu, B; Ercan, I; Gozu, RO; Ilcol, YO; Karadag, M; Ursavas, A | 1 |
| Goldbart, AD; Goldman, JL; Gozal, D; Kheirandish-Gozal, L; Mager, E; Piedimonte, G; Serpero, LD; Veling, MC | 1 |
| Al-Abri, M; Cross, MD; Douglas, NJ; Mackay, TW; Mills, NL; Newby, DE; Riha, R; Vennelle, M | 1 |
| Ursavas, A | 1 |
1 review(s) available for substance p and Apnea, Obstructive Sleep
| Article | Year |
|---|---|
Upregulating substance P levels to treat obstructive sleep apnea.
Topics: Controlled Clinical Trials as Topic; Disorders of Excessive Somnolence; Humans; Infusions, Intravenous; Receptors, Neurokinin-1; Sleep Apnea, Obstructive; Substance P; Up-Regulation | 2008 |
1 trial(s) available for substance p and Apnea, Obstructive Sleep
| Article | Year |
|---|---|
Continuous positive airway pressure improves vascular function in obstructive sleep apnoea/hypopnoea syndrome: a randomised controlled trial.
Topics: Acetylcholine; Adult; Cardiovascular Diseases; Continuous Positive Airway Pressure; Double-Blind Method; Female; Humans; Hypoxia; Male; Middle Aged; Nitroprusside; Sleep Apnea, Obstructive; Substance P; Vasodilation; Vasodilator Agents | 2008 |
6 other study(ies) available for substance p and Apnea, Obstructive Sleep
| Article | Year |
|---|---|
Substance P and neurokinin 1 receptors as potential therapeutic targets in children with OSA.
Topics: Cell Culture Techniques; Cell Proliferation; Child; Cytokines; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Humans; Neurokinin-1 Receptor Antagonists; Palatine Tonsil; Physalaemin; Receptors, Neurokinin-1; Signal Transduction; Sleep Apnea, Obstructive; Substance P | 2014 |
[Relationship between serum substance P levels and excessive daytime sleepiness in patients with obstructive sleep apnea-hypopnea syndrome].
Topics: Adult; Case-Control Studies; Disorders of Excessive Somnolence; Female; Humans; Male; Middle Aged; Sleep Apnea, Obstructive; Sleep Stages; Substance P | 2012 |
[The relationship between content of substance P, VIP in pharyngeal tissue and narrow pharyngeal cavity of patients with OSAS].
Topics: Adult; Female; Humans; Male; Middle Aged; Pharyngeal Diseases; Sleep Apnea, Obstructive; Substance P; Vasoactive Intestinal Peptide | 2001 |
Substance P in the midbrains of SIDS victims and its correlation with sleep apnea.
Topics: Double-Blind Method; Female; Humans; Immunohistochemistry; Infant; Infant, Newborn; Male; Mesencephalon; Polysomnography; Prospective Studies; Sleep Apnea, Obstructive; Statistics, Nonparametric; Substance P; Sudden Infant Death; Supine Position | 2003 |
Relationship between serum substance P levels and daytime sleepiness in obstructive sleep apnea syndrome.
Topics: Dyssomnias; Female; Humans; Hypoxia; Male; Matched-Pair Analysis; Middle Aged; Polysomnography; Severity of Illness Index; Sleep Apnea, Obstructive; Substance P | 2007 |
Neurotrophins and tonsillar hypertrophy in children with obstructive sleep apnea.
Topics: Adenoids; Brain-Derived Neurotrophic Factor; Child; Child, Preschool; Female; Humans; Hypertrophy; Male; Nerve Growth Factor; Nerve Growth Factors; Palatine Tonsil; Receptor, trkA; Receptors, Neurokinin-1; Respiratory Syncytial Virus Infections; RNA, Messenger; Sleep Apnea, Obstructive; Substance P; Tonsillitis | 2007 |